Unlock China’s Medtech Market — with clarity, access, and the right partners 

China continues to scale as one of the most important medtech markets globally — but success requires a precise understanding of regulatory paths, local stakeholders, and how real decisions are made.

The Medtech Executive China Bootcamp (MECB) at the HKUST Shanghai Center is a focused 4-day immersion for founders, executives, and innovators preparing for China market entry or expansion. The program combines expert-led learning, field exposure, and practical workshops designed to help ventures move from interest to informed action.

What Makes MECB Different

  • Experience direct access to top regulators, investors, hospital leaders, and legal experts—get real, actionable insights from decision makers who shape the world’s second largest medtech market.

  • Throughout the camp, collaborative sessions and networking events provide valuable opportunities to connect with peers, experts, and potential partners across the Shanghai innovation ecosystem.

  • In just four days, gain hands-on exposure, master regulatory pathways (NMPA), and refine your China strategy with input from seasoned practitioners and sector specialists.  

  • Go beyond surface learning: the camp format includes practical workshops and peer discussions that encourage participants to address real business challenges together, fostering non-generic, venture-relevant solutions.

  • Speakers include senior leaders from McKinsey & Co., Medtronic GC Ventures, Genesis Medtech, Pulnovo Medical, CCRC Medtech, Bioworld Ventures, and many more.  

Program Outcomes

  • A strategic China market plan, built on ground-level research and expert feedback, tailored to your venture needs and ready to present to your board or executive team.

  • Supported with China readiness assessment and strategic hypothesis

  • Practical inputs and risks directly informed by experts and operators

  • Network pathways for partnerships, pilots, and future collaboration

  • Eligibility consideration for HKUST Shanghai Center’s Medtech Acceleration Program  

Enrolment & Early-Bird Details

The program is intentionally small to preserve quality of interaction and personalized guidance. Early-bird priority enrolment is now open until 31 December 2025. Final pricing, inclusions, and schedule are available in the program deck.

Application requires: 

1️⃣ Venture profile; 
2️⃣ Team details; 
3️⃣ Key learning objectives

Program Deck

Enquiry

ebootcamp@ust.hk